John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVM
1326
DELISTED
Adverum Biotechnologies
ADVM
| $2.06M | 0.01% |
156,860
-19,768
| -11% | -$289K |
|
1327
Nutrien
NTR
$35.5B
| $2.05M | 0.01% |
+19,755
| New | +$1.64M |
|
1328
First Commonwealth Financial
FCF
$2.12B
| $2.05M | 0.01% |
135,434
-88,746
| -40% | -$1.44M |
|
1329
Cushman & Wakefield Ltd
CWK
$3.44B
| $2.04M | 0.01% |
99,700
-362,816
| -78% | -$7.68M |
|
|
TCRR
1330
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.04M | 0.01% |
739,779
-24,625
| -3% | -$77.5K |
|
|
AVLR
1331
DELISTED
Avalara, Inc.
AVLR
| $2.04M | 0.01% |
20,524
-5,815
| -22% | -$589K |
|
1332
Future Fuel
FF
$241M
| $2.04M | 0.01% |
209,615
-14,762
| -7% | -$120K |
|
|
OGI
1333
Organigram Holdings
OGI
$178M
| $2.04M | 0.01% |
306,571
-479,386
| -61% | -$2.96M |
|
1334
Kadant
KAI
$3.69B
| $2.03M | 0.01% |
10,461
+8,461
| +423% | +$1.73M |
|
|
GLOP
1335
DELISTED
GASLOG PARTNERS LP
GLOP
| $2.03M | 0.01% |
+352,595
| New | +$1.51M |
|
1336
Universal Technical Institute
UTI
$1.21B
| $2M | 0.01% |
226,404
+62,694
| +38% | +$514K |
|
|
LBBBU
1337
DELISTED
Lakeshore Acquisition II Corp. Unit
LBBBU
| $2M | 0.01% |
+200,000
| New | +$2M |
|
1338
JELD-WEN Holding
JELD
$216M
| $1.99M | 0.01% |
+98,153
| New | +$2.31M |
|
1339
Community Health Systems
CYH
$424M
| $1.99M | 0.01% |
167,580
-730,613
| -81% | -$8.88M |
|
|
BWAQ
1340
DELISTED
Blue World Acquisition Corporation Class A Ordinary Shares
BWAQ
| $1.98M | 0.01% |
+199,998
| New | +$1.97M |
|
1341
Sana Biotechnology
SANA
$1.13B
| $1.97M | 0.01% |
238,047
+158,786
| +200% | +$1.28M |
|
1342
Peoples Bancorp
PEBO
$1.43B
| $1.96M | 0.01% |
62,517
-16,377
| -21% | -$531K |
|
1343
National Bank Holdings
NBHC
$1.86B
| $1.96M | 0.01% |
48,553
+17,784
| +58% | +$790K |
|
1344
Appian
APPN
$2.81B
| $1.95M | 0.01% |
32,007
-124,607
| -80% | -$7.07M |
|
|
CIVI
1345
DELISTED
Civitas Resources
CIVI
| $1.95M | 0.01% |
+32,606
| New | +$1.77M |
|
|
FMTX
1346
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.93M | 0.01% |
207,469
+137,979
| +199% | +$1.47M |
|
1347
Deckers Outdoor
DECK
$12.5B
| $1.92M | 0.01% |
+42,138
| New | +$2.09M |
|
1348
National Presto Industries
NPK
$1.11B
| $1.92M | 0.01% |
24,989
+18,984
| +316% | +$1.54M |
|
1349
Snap-on
SNA
$20.4B
| $1.92M | 0.01% |
9,352
-7,019
| -43% | -$1.48M |
|
1350
Axcelis
ACLS
$3.81B
| $1.92M | 0.01% |
25,429
-8,416
| -25% | -$575K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.